In addition, Czaplinska et al. found that fibroblast growth factor receptor 2 (FGFR2) can form an indirect complex with RSK2, which may be involved in the progression of breast cancer and lead to poor prognosis in breast cancer patients (Czaplinska et al., 2016). The gene discussed is RPS6KA3; the disease is breast carcinoma.